35 Results

People

  1. Younes
    Younes
  2. Zelenetz
    Zelenetz
  3. Batlevi
    Batlevi
  4. Kumar
    Kumar
  5. Gerecitano
    Gerecitano
  6. Hamlin
    Hamlin
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Moskowitz
    Moskowitz
  10. Noy
    Noy

Groups

  1. Center for Hematologic Malignancies (35)
  2. Department of Medicine (35)
  3. Executive Committee, Center for Hematologic Malignancies (35)
  4. Hematologic Malignancies, Division of (35)
  5. Lymphoma (35)
  6. Epidemiology and Biostatistics (13)
  7. Sloan Kettering Institute Postdocs (12)
  8. Biostatistics Service (10)
  9. Center for Pancreatic Cancer Research (9)
  10. GSK Faculty (8)
  1. "article"
  2. "Anas Younes"
  3. "Lymphoma"
Formats
  1. Journal Article (35)
Groups
  1. Center for Hematologic Malignancies (35)
  2. Department of Medicine (35)
  3. Executive Committee, Center for Hematologic Malignancies (35)
  4. Hematologic Malignancies, Division of (35)
  5. Lymphoma (35)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Anas Younes (35)
  2. Andrew Zelenetz (11)
  3. Anita Kumar (10)
  4. Connie Batlevi (10)
  5. David Straus (8)
  6. John Gerecitano (8)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publications
  1. Blood (5)
  2. Haematologica (3)
  3. Leukemia and Lymphoma (3)
  4. Blood Advances (2)
  5. British Journal of Haematology (2)
  6. Lancet Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Science, Inc. (3)
  3. Ferrata Storti Foundation (3)
  4. Nature Publishing Group (3)
  5. Taylor & Francis Group (3)
  6. John Wiley & Sons (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPĪ± checkpoint blocker
    Journal Article

    Dacek, M. M.; Kurtz, K. G.; Wallisch, P.; Pierre, S. A.; Khayat, S.; Bourne, C. M.; Gardner, T. J.; Vogt, K. C.; Aquino, N.; Younes, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Diefenbach, C.; Ferrari, S.; Khan, C.; Sharman, J. P.; Tani, M.; Ujjani, C.; Vitolo, U.; Yuen, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma
    Journal Article

    Fischer, T.; Ni, A.; Bantilan, K. S.; Soumerai, J. D.; Alperovich, A.; Batlevi, C.; Younes, A.; Zelenetz, A. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save